Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$684M |
| 2 |
Amgen
AMGN
|
+$653M |
| 3 |
Salesforce
CRM
|
+$488M |
| 4 |
Eli Lilly
LLY
|
+$452M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$437M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$815M |
| 2 |
NVIDIA
NVDA
|
+$685M |
| 3 |
TJX Companies
TJX
|
+$488M |
| 4 |
Starbucks
SBUX
|
+$373M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.92% |
| 2 | Healthcare | 18.9% |
| 3 | Consumer Discretionary | 9.38% |
| 4 | Financials | 9.11% |
| 5 | Industrials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Medtronic
MDT
$107B
| $191M | 0.1% |
2,430,651
-1,056,843
| -30% | -$86.6M |
|
177
Dentsply Sirona
XRAY
$2.59B
| $188M | 0.1% |
7,562,367
+29,903
| +0.4% | +$858K |
|
178
Micron Technology
MU
$1.04T
| $187M | 0.1% |
1,424,787
-701,294
| -33% | -$88.4M |
|
|
AVDL
179
DELISTED
Avadel Pharmaceuticals
AVDL
| $187M | 0.1% |
13,297,317
+382,157
| +3% | +$6.23M |
|
|
GTLS
180
DELISTED
Chart Industries
GTLS
| $183M | 0.1% |
1,266,744
+166,791
| +15% | +$25.2M |
|
181
Ryan Specialty Holdings
RYAN
$5.41B
| $182M | 0.1% |
3,134,930
+39,126
| +1% | +$2.09M |
|
182
Qualcomm
QCOM
$176B
| $181M | 0.1% |
909,128
-570,681
| -39% | -$108M |
|
183
Walker & Dunlop
WD
$1.65B
| $180M | 0.1% |
1,836,027
-162,118
| -8% | -$15.4M |
|
184
Revolution Medicines
RVMD
$40.2B
| $180M | 0.1% |
4,640,218
+728,099
| +19% | +$27.2M |
|
185
Dollar Tree
DLTR
$23.1B
| $179M | 0.1% |
1,679,364
+315,938
| +23% | +$37.3M |
|
186
Wayfair
W
$11.1B
| $177M | 0.1% |
3,363,518
+1,735,806
| +107% | +$103M |
|
187
Coca-Cola
KO
$354B
| $175M | 0.09% |
2,750,209
+288,247
| +12% | +$17.8M |
|
|
CTLT
188
DELISTED
CATALENT, INC.
CTLT
| $174M | 0.09% |
3,094,620
-6,466,078
| -68% | -$361M |
|
189
Ziff Davis
ZD
$1.9B
| $174M | 0.09% |
3,152,339
-87,315
| -3% | -$4.8M |
|
190
Glaukos
GKOS
$9.02B
| $172M | 0.09% |
1,457,533
-153,355
| -10% | -$16.3M |
|
191
Sotera Health
SHC
$4.95B
| $172M | 0.09% |
14,492,836
-400,032
| -3% | -$4.57M |
|
192
Mirum Pharmaceuticals
MIRM
$6.89B
| $171M | 0.09% |
4,988,747
+2,221,537
| +80% | +$58.2M |
|
193
Prologis
PLD
$138B
| $166M | 0.09% |
1,474,801
-189,535
| -11% | -$21M |
|
194
Sensient Technologies
SXT
$5.4B
| $165M | 0.09% |
2,229,750
-181,683
| -8% | -$13.3M |
|
195
Motorola Solutions
MSI
$69.4B
| $165M | 0.09% |
426,836
+68,630
| +19% | +$24.8M |
|
196
Capital One
COF
$124B
| $165M | 0.09% |
1,190,082
-26,642
| -2% | -$3.74M |
|
197
Dyne Therapeutics
DYN
$4.04B
| $163M | 0.09% |
4,623,824
+1,948,584
| +73% | +$56.6M |
|
198
AXIS Capital
AXS
$8.59B
| $163M | 0.09% |
2,302,960
-18,311
| -0.8% | -$1.24M |
|
199
OSI Systems
OSIS
$3.57B
| $162M | 0.09% |
1,179,310
-70,579
| -6% | -$9.73M |
|
200
Marathon Petroleum
MPC
$90.3B
| $162M | 0.09% |
934,320
-298,159
| -24% | -$55.5M |
|
Similar funds
Janus Henderson Group's Q2 2024 Portfolio in Review
As of Q2 2024, Janus Henderson Group held 2,619 positions worth $187B, up 1.9% from $183B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Janus Henderson Group's Q2 2024 filing shows 91 new, 630 increased, 1,758 reduced and 101 closed positions. Its largest new stake was UL Solutions: 2,328,210 shares worth $98.2M. The largest sale was Adobe, an estimated $815M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2024 buy was UL Solutions: 2,328,210 shares worth $98.2M.
- Janus Henderson Group added most to Broadcom in Q2 2024, an estimated $684M increase.
- Janus Henderson Group's biggest Q2 2024 reduction was Adobe, cutting an estimated $815M.
- Janus Henderson Group fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $157M.
- Janus Henderson Group's ten largest holdings make up 32% of its $187B portfolio in Q2 2024.
- Janus Henderson Group opened 91 new positions and closed 101 in Q2 2024.
- Janus Henderson Group's portfolio value rose 1.9% quarter-over-quarter to $187B.
Based on Janus Henderson Group's 13F filing for Q2 2024, filed 14 Aug 2024.